Quantabio’s Post

Checkout our most recent paper published in Journal of Clinical Microbiology (JCM) by first author Vinayaraj EV, PhD. I am lucky and privileged 😁 to contribute into the findings of the present study which shows the clinical and laboratory evidence of autochthonous cases of Anaplasma phagocytophilum in North India. #anaplasma #jcm #tickbornediseases #northindia #emergingdisease https://lnkd.in/gR7X6-Jd

Elevate Your Patient Care with Mantara PGx Testing 🧬💊 Improve your medical decision-making with Mantara's cutting-edge DNA testing, backed by the latest pharmacogenomic evidence and expert guidance from leading UK and European experts. Leveraging protocols from the renowned UPGx PREPARE study in The Lancet 2023, our reports offer you the confidence to prescribe accurately within approved guidelines. 🔬 Our world-class German lab and partnership with bio.logis ensure high-quality, reliable DNA genotyping and clear, actionable reports. This means you can consider genetic factors with certainty in your prescribing decisions, aligning with SmPCs that recommend genetic insights. 💡 With actionable advice from the Dutch Pharmacogenetics Working Group and validated by significant studies, Mantara® PGx reports are your key to informed, precise prescription choices. Interested in integrating pharmacogenomics into your practice or research? Let's connect. Your journey to more personalised patient care starts here. 🌟 #PrecisionMedicine #Pharmacogenomics #HealthcareInnovation

We are honoured to have participated in the 197th C-CAMP InDx Round Table that highlighted key advancements in diagnostics, focusing on indigenous MPox IVD kits. Dr. Akhilesh Rawat, General Manager – R&D Reagents, Transasia Bio-Medicals Ltd. highlighted the latest advancements and provided updates on CDSCO-approved ErbaMDx MonkeyPox RT-PCR Kit - India’s first indigenously developed kit. The kit's lyophilized components, which allow for shipping and storage at ambient temperatures, are particularly advantageous for deployment in regions with limited cold chain infrastructure. This feature expands access to reliable diagnostics in underserved areas, helping to bridge the healthcare gap in critical situations. Further, ErbaMDx Monkey Pox Real Time PCR Kit is designed for use with commercially available open-platform real-time PCR systems. Consequently, it is suitable for application in any PCR testing laboratory developed for molecular diagnostics testing during the COVID-19 pandemic. The event featured an engaging Q&A session with experts on the validation process for these diagnostics. This round table was a key platform for discussing the progress of indigenous MPox diagnostics and their approval status, emphasizing the collaborative efforts in advancing public health solutions. Dr. Manoj Chugh Dr. Akhilesh Rawat #IAmTransasia #WeAreErba #CCAMPInDxRoundTable #MPox #Diagnostics #IVDValidation #IndigenousIVD #MPXV #Monkeypox #qPCR #PublicHealth #PandemicPrevention #IndiaPreparedness #GlobalReach #ZoonoticDiseases #ClinicalTrials #AtmaNirbharBharat #RTPCR #molecular

We are honoured to have participated in the 197th C-CAMP InDx Round Table that highlighted key advancements in diagnostics, focusing on indigenous MPox IVD kits. Dr. Akhilesh Rawat, General Manager – R&D Reagents, Transasia Bio-Medicals Ltd. highlighted the latest advancements and provided updates on CDSCO-approved ErbaMDx MonkeyPox RT-PCR Kit - India’s first indigenously developed kit. The kit's lyophilized components, which allow for shipping and storage at ambient temperatures, are particularly advantageous for deployment in regions with limited cold chain infrastructure. This feature expands access to reliable diagnostics in underserved areas, helping to bridge the healthcare gap in critical situations. Further, ErbaMDx Monkey Pox Real Time PCR Kit is designed for use with commercially available open-platform real-time PCR systems. Consequently, it is suitable for application in any PCR testing laboratory developed for molecular diagnostics testing during the COVID-19 pandemic. The event featured an engaging Q&A session with experts on the validation process for these diagnostics. This round table was a key platform for discussing the progress of indigenous MPox diagnostics and their approval status, emphasizing the collaborative efforts in advancing public health solutions. #IAmTransasia #WeAreErba #CCAMPInDxRoundTable #MPox #Diagnostics #IVDValidation #IndigenousIVD #MPXV #Monkeypox #qPCR #PublicHealth #PandemicPrevention #IndiaPreparedness #GlobalReach #ZoonoticDiseases #ClinicalTrials #AtmaNirbharBharat #RTPCR #molecular

We’re proud to announce that Dr. Ariel Pradipta, M.Res, Ph.D., Chief of Science at Genomik Solidaritas Indonesia, will represent GSI at the prestigious London Calling Clinical & Biopharma Day! 🎉 Dr. Ariel Pradipta will present a groundbreaking poster on "Tuberculosis Drug Resistance Surveillance using Oxford Nanopore Technologies." Discover how the tNGS workflow offers rapid results in just 26 hours, outpacing standard culture-based methods. This technique provides quick, reliable categorization of TB resistance profiles, unaffected by sample concentration, which is crucial for improving management guidelines in high-burden regions. 🌍🔬 📍 Location: 1 Old Billingsgate Walk (Riverside), 16 Lower Thames St, London EC3R 6DX 🗓 Date: Friday, 24th May ⏰ Time: 10:30 – 11:05 BST Don’t miss this chance to explore cutting-edge advancements in TB drug resistance research! #GenomikaIndonesia #LondonCalling #ClinicalBiopharma #OxfordNanopore #ScientificPresentation #InnovationInScience #TuberculosisResearch #RapidDiagnostics

NalaGenetics at The 2nd Anniversary of Biomedical and Genomic Science Initiatives (BGSi) for Precision Medicine! We were thrilled to be part of this monumental event, celebrating BGSi's strides in transforming healthcare through precision medicine and genomic data. The Indonesian Ministry of Health's (Ministry of Health of the Republic of Indonesia) initiative has been pivotal in creating a national genomic strategic plan, with the ultimate goal of making healthcare more inclusive, personalized, and effective. During the session "Building Pharmacogenomics Capacity in Public Hospitals", we were honored to have dr. Bambang Widyantoro, Sp.JP, PhD (RS Harapan Kita) highlight NalaGenetics' contributions in personalizing heart disease treatments through pharmacogenomics. Alongside esteemed panelists like dr. Beny Rilianto, Sp.N (K) (RS Pusat Otak Nasional), Dr. dr. I Gusti Nyoman Darmaputra, Sp.KK (K) (RSUP Prof Dr. I.G.N.G Ngoerah), and Dr. dr. Nova Riyanti Yusuf, Sp.KJ (RSJ Marzoeki Mahdi), we discussed how genomic data is revolutionizing healthcare. Here's to advancing healthcare in Indonesia through genomics! Thank you for the opportunity, and we can't wait for the next event! 💡 #NalaGenetics #BGSi #PrecisionMedicine #Genomics #Pharmacogenomics #PersonalizedHealthcare

Exciting News from COLOTAN 4th Symposium!    On January 10th, join Prof. Amin Rostami-Hodjegan, CSO of Certara, in Cork, Ireland, for the annual Symposium of this influential EU research network. He'll delve into the intricacies of Crohn's Disease, shedding light on precision dosing and its profound impact.   Amin will explore the pursuit of optimal dosing in orphan disease populations, emphasizing the crucial role of virtual trials powered by Physiologically Based Pharmacokinetics (PBPK) in tailoring individual drug dosages. These trials tackle challenges in drug development for orphan diseases and subpopulations with comorbidities. At Certara, our research teams are committed to investing in platforms that unlock the transformative potential of virtual clinical studies. Discover more about COLOTAN and explore the lineup of presentations at: https://ow.ly/1lbL50QoOvf. For deeper insights into PBPK, visit https://lnkd.in/eStKcKZ3.   #COLOTAN4thSymposium #PrecisionDosing #PBPK #CrohnsDisease #Bioequivalence #InnovationInMedicine #ClinicalResearch

HAPPY NEW YEAR 🎆🎆🎆 This new year starts with some good news. Today, a staggering 200 million plus individuals are living with Atopic Dermatitis (AD), and this figure continues to climb in face of deteriorating air quality and increasing environmental stressors. Unfortunately, 1/5 of these cases involves young children aged 1-4, which often trouble the kids themselves as well as their caregivers. Despite AD being non-fatal, it's hard for us to overlook the disease as it often relapses and can persist throughout a person's lifetime. The latest publication highlights the efficacy of our ingredient Oligo Fucoidan as a powerful active in improving AD conditions. It offers a versatile solution for both oral and topical applications. #hiq #hiqbio #marinefucoidanexpert #oligofucoidan #olifuco #fucoskin #atopicdermatitis #dailycare #healthyskin

Getting to know Murielle Veniant, PhD. has been one of the highlights of my first few months on Amgen's Obesity and Related Conditions team. #mycompany 🎧 📘 Read or listen to the latest Amgen story about Murielle: https://lnkd.in/eaWUhH5w.

𝐇𝐚𝐩𝐩𝐲 𝐭𝐨 𝐒𝐡𝐚𝐫𝐞 𝐚 𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐢𝐧 𝐌𝐲 𝐀𝐜𝐚𝐝𝐞𝐦𝐢𝐜 𝐏𝐚𝐭𝐡! Dear Connections, I am delighted to share that my conference paper titled "𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝘁𝗮-𝗗𝗿𝗶𝘃𝗲𝗻 𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗜𝗺𝗺𝘂𝗻𝗲 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲𝘀 𝗮𝗻𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗘𝗳𝗳𝗶𝗰𝗮𝗰𝘆" has been published and presented at the International Scientific and Practical Conference on 𝗦𝘁𝗮𝘁𝘂𝘀 𝗮𝗻𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀 𝗼𝗳 𝗙𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹 𝗮𝗻𝗱 𝗔𝗽𝗽𝗹𝗶𝗲𝗱 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗹𝗼𝗴𝘆: 𝗧𝗵𝗲 𝗩𝗶𝗲𝘄𝗽𝗼𝗶𝗻𝘁 𝗼𝗳 𝗬𝗼𝘂𝗻𝗴 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀, held by the Institute of Microbiology of the Academy of Sciences of the Republic of Uzbekistan. This work was a collaborative effort with my co-authors: Ayeza Sarwar Kalam Asim Rahman Dr. Md. Faheem Haider Sir. In this research, we explore how gut microbiota influences immune responses and its implications for vaccine efficacy, highlighting its vital role in preventive healthcare. You can read more about the conference paper here: https://lnkd.in/gEtZPNva A big thank you to everyone involved and to the Institute of Microbiology for organizing such an impactful event! #Pharmacy #Microbiota #Research #VaccineEfficacy